Jane Street Group LLC lowered its position in shares of Aemetis, Inc. (NASDAQ:AMTX – Free Report) by 18.4% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 30,407 shares of the specialty chemicals company’s stock after selling 6,856 shares during the quarter. Jane Street Group LLC owned 0.06% of Aemetis worth $70,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of the stock. FMR LLC lifted its stake in Aemetis by 68.2% in the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock worth $52,000 after acquiring an additional 9,137 shares in the last quarter. Rhumbline Advisers grew its holdings in Aemetis by 2,837.1% in the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock valued at $157,000 after buying an additional 50,528 shares during the last quarter. Wellington Management Group LLP acquired a new stake in Aemetis in the 3rd quarter valued at approximately $177,000. Bank of New York Mellon Corp acquired a new stake in shares of Aemetis during the 2nd quarter worth approximately $306,000. Finally, Susquehanna Fundamental Investments LLC grew its holdings in shares of Aemetis by 287.4% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock worth $379,000 after purchasing an additional 93,536 shares in the last quarter. 27.02% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several equities analysts recently commented on AMTX shares. StockNews.com upgraded Aemetis to a “sell” rating in a research report on Friday, January 3rd. HC Wainwright restated a “buy” rating and set a $28.00 target price on shares of Aemetis in a research report on Monday, December 23rd. One analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, Aemetis has an average rating of “Moderate Buy” and an average target price of $12.95.
Aemetis Stock Up 7.7 %
Shares of NASDAQ:AMTX opened at $2.80 on Thursday. The firm has a market cap of $139.26 million, a price-to-earnings ratio of -1.24 and a beta of 1.47. Aemetis, Inc. has a 12 month low of $2.10 and a 12 month high of $7.03. The company’s fifty day simple moving average is $3.27 and its 200 day simple moving average is $2.96.
Aemetis (NASDAQ:AMTX – Get Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, topping the consensus estimate of ($0.47) by $0.09. The business had revenue of $81.44 million for the quarter, compared to the consensus estimate of $77.79 million. During the same period in the prior year, the business earned ($0.59) earnings per share. Research analysts expect that Aemetis, Inc. will post -2.02 earnings per share for the current fiscal year.
About Aemetis
Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.
Featured Articles
- Five stocks we like better than Aemetis
- Are Penny Stocks a Good Fit for Your Portfolio?
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- There Are Different Types of Stock To Invest In
- How Do Stock Buybacks Affect Shareholders?
- Trading Stocks: RSI and Why it’s Useful
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.